4-(4-CHLORO-3,5-DIMETHYLPHENOXY)ANILINE
![]() |
- $205 - $802.73
- Product name: 4-(4-CHLORO-3,5-DIMETHYLPHENOXY)ANILINE
- CAS: 150418-62-5
- MF: C14H14ClNO
- MW: 247.72
- EINECS:
- MDL Number:MFCD02663371
- Synonyms:4-(4-CHLORO-3,5-DIMETHYLPHENOXY)ANILINE;BENZENAMINE, 4-(4-CHLORO-3,5-DIMETHYLPHENOXY)-;4-(4-Chloro-3,5-dimethylphenoxy)benzenamine
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number4657AD
- Product description4-(4-Chloro-3,5-dimethylphenoxy)aniline
- Packaging500mg
- Price$326
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0069858
- Product description4-(4-CHLORO-3,5-DIMETHYLPHENOXY)ANILINE 95.00%
- Packaging500MG
- Price$802.73
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12139627
- Product description4-(4-Chloro-3,5-dimethylphenoxy)aniline 97%
- Packaging5g
- Price$648
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number022462
- Product description4-(4-Chloro-3,5-dimethylphenoxy)aniline
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 4657AD | 4-(4-Chloro-3,5-dimethylphenoxy)aniline | 500mg | $326 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0069858 | 4-(4-CHLORO-3,5-DIMETHYLPHENOXY)ANILINE 95.00% | 500MG | $802.73 | 2021-12-16 | Buy |
Crysdot | CD12139627 | 4-(4-Chloro-3,5-dimethylphenoxy)aniline 97% | 5g | $648 | 2021-12-16 | Buy |
Matrix Scientific | 022462 | 4-(4-Chloro-3,5-dimethylphenoxy)aniline | 500mg | $205 | 2021-12-16 | Buy |
Properties
Boiling point :373.8±42.0 °C(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :4.63±0.10(Predicted)
Density :1?+-.0.06 g/cm3(Predicted)
pka :4.63±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|